Structural and Energetic Evidence for Highly Peptide-Specific Tumor Antigen Targeting via Allo-MHC Restriction

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1108422109
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Targeting Cancers Through TCR-peptide/MHC Interactions

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Functional Avidity of Tumor Antigen-Specific CTL Recognition Directly Correlates With the Stability of MHC/Peptide Multimer Binding to TCR

Journal of Immunology
AllergyImmunology
2002English

Antigen Processing for MHC Class II Presentation via Autophagy

Frontiers in Immunology
AllergyImmunology
2012English

Immunomodulation of Breast Cancer via Tumor Antigen Specific Th1

Cancer Research and Treatment
Cancer ResearchOncology
2009English

Targeting Liposomal Chemotherapy via Both Tumor Cell-Specific and Tumor Vasculature-Specific Ligands Potentiates Therapeutic Efficacy

Cancer Research
Cancer ResearchOncology
2006English

Accurate Structure Prediction of Peptide–MHC Complexes for Identifying Highly Immunogenic Antigens

Molecular Immunology
ImmunologyMolecular Biology
2013English

Tracking Tumor Evolution via Prostate-Specific Antigen: An Individual Post-Operative Study

Theoretical Biology and Medical Modelling
MedicineModelingSimulationHealth Informatics
2010English

Induction and Isolation of Tumor Antigen-Specific CD4+ T Lymphocytes Using Sorting Signal Directed MHC Class-Ii Expression

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Tumor Targeting via Integrin Ligands

Frontiers in Oncology
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy